SEC Comment Letter 0000000000-25-001124 to OSR Health, Inc. (OSRH)

OSR Health, Inc.
Date: Feb. 3, 2025 · CIK: 0001840425 · Accession: 0000000000-25-001124

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-41390

Date

February 3, 2025

Author

Kuk Hyoun Hwang

Form

UPLOAD

Company

OSR Health, Inc.

Letter

February 3, 2025 Kuk Hyoun Hwang Chief Executive Officer Bellevue Life Sciences Acquisition Corp. 10900 NE 4th Street Suite 2300 Bellevue, WA 98004 Re:Bellevue Life Sciences Acquisition Corp. Form 10-K for the Fiscal Year Ending December 31, 2022 File No. 001-41390 Dear Kuk Hyoun Hwang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Real Estate & Construction

Show Raw Text

February 3, 2025
Kuk Hyoun Hwang
Chief Executive Officer
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
Re:Bellevue Life Sciences Acquisition Corp.
Form 10-K for the Fiscal Year Ending December 31, 2022
File No. 001-41390
Dear Kuk Hyoun Hwang:
            We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction

SecProbe.io